Injective price surged 11.88% to $4.84 on May 12 as a single announcement repositioned INJ at the center of Cosmos stablecoin infrastructure. Volume hit $163 million, up 122%, driving the vol-to-market-cap ratio to 33% against a $484 million market cap. Injective coin has gained 60.53% over the past month and 31.38% over the past week.
INJ Fills the $77B Liquidity Gap Left by Noble’s EVM Migration
Noble USDC, the prior Cosmos standard, migrated its SDK chain into maintenance mode after pivoting to its own EVM L1, leaving $77 billion in ecosystem stablecoin liquidity without a credible long-term issuer.
Injective fills that gap directly, with Skip: Go confirming it as the default USDC denomination and enabling one-signature cross-chain transfers, sub-second finality, and near-zero gas costs with CCTP support.
The integration is locked for a minimum of four years, with dYdX first in line for rollout. A portion of fees generated by Injective USDC will be routed to programmatic ATOM buybacks, aligning Cosmos Hub revenue with Injective’s on-chain activity. And that’s not where the institutional stack ends.
Bitnomial recently launched the first U.S. CFTC-regulated INJ futures, and Kraken has since acquired Bitnomial for $550 million, slotting INJ into execution infrastructure that institutional desks already rely on.
At Consensus 2026, Bitnomial President Michael Dunn and Canary Funds CEO Steven McClurg cited Injective as one of the few digital assets with both active regulated futures and ETF filings in motion.
Additionally, INJ ranked in the top 10 networks by trailing 30-day revenue, and the $196,000 community buyback, the highest participation on record, was cleared in under 10 minutes.
Injective Price Presses $5.56 Ceiling With Momentum Stretched
The daily price of Injective coin is running into the $5.56 resistance band, levels that capped the prior rally through late 2025 before the price dropped back to the February cycle low at $2.735.
The relative strength index is currently over 80%, and the ADR is 0.269, putting the average daily swing at roughly $0.26 over the past two weeks; today’s session has already printed a range nearly 40% wider than that, with volume confirming that buyers are driving the expansion.
Stretched momentum doesn’t rule out continuation, but it compresses the risk-reward for new longs approaching that ceiling.
The Injective price prediction from here depends on whether buyers absorb the $5.56 zone on volume: a weekly close above it removes the nearest structural obstacle, while rejection returns Injective coin to the mid-$4 range.
READ MORE: Bitcoin Price Forms Alarming Pattern as Ray Dalio Delivers Key Warning
